Biotech and pharma leaders are invited to join CMIC for an exclusive in-person lunch and networking event focused on expanding drug development into Japan and the broader Asia-Pacific (APAC) region.

Learn how Japan serves as a strategic gateway to high-value APAC markets — South Korea, Australia, Taiwan, and Southeast Asia — and how to advance clinical development through local expertise.

The program will conclude with an interactive panel discussion and Q&A. More details on speakers and presentations will be shared in the coming weeks.

Register for the lunch and learn here: https://en.cmicgroup.com/massbio_2026_eventregistration/ 

Your Trusted Service Partner for the US, Japan and Asia


Better Medicine, Sooner

CMIC Group was founded in 1992 as the first contract research organization (CRO) in Japan. To enable pharmaceutical and biotech companies to develop better medicine sooner, we expanded our solutions to contract development and manufacturing (CDMO), site management (SMO), and market solutions. We also support global drug development companies in bringing highly desired treatments to the Japanese market. CMIC also contributes to the broader healthcare market. Leveraging our vast experience and expertise in the medical industry, we offer solutions through a new healthcare ecosystem to support individuals and local governments. We strive to be a Personal Health Value Creator (PHVC) to meet our global customers’ needs in the U.S., Japan, and across Asia.

Learn more about our global capabilities and support:

• United States Services & Locations:
  
  https://en.cmicgroup.com/cmic-usa-services/ 
• Japan Services & Locations:
  
  https://en.cmicgroup.com/cmic-japan-services/ 
• APAC Services & Locations: https://en.cmicgroup.com/cmic-apac-services/